Biotechs: Proving Prevention Really is Better than the Cure

By
Dr Bianca Ogden,
User

Molecular biology was Bianca’s first love before she discovered the joys and challenges of investing. After spending some time at Swiss pharmaceuticals company Novartis.. More

15 May 2020

The global healthcare sector has undergone significant change over the past 20 years with more to come, largely driven by advances in the dynamic biotech sector. Involved in such things as antibody therapies, protein engineering, gene editing, immunology and diagnostic tools, the biotech industry has made an indelible impact on our lives. Read more

This article featured in the April 2020 issue of the Australian Shareholders’ Association (ASA) Equity newsletter.


DISCLAIMER: This article has been prepared by Platinum Investment Management Limited ABN 25 063 565 006, AFSL 221935, trading as Platinum Asset Management (“Platinum”). This information is general in nature and does not take into account your specific needs or circumstances. You should consider your own financial position, objectives and requirements and seek professional financial advice before making any financial decisions. The commentary reflects Platinum’s views and beliefs at the time of preparation, which are subject to change without notice. No representations or warranties are made by Platinum as to their accuracy or reliability. To the extent permitted by law, no liability is accepted by Platinum for any loss or damage as a result of any reliance on this information.